Clinical Benefit of Glasdegib in Combination with Azacitidine or Low-Dose Cytarabine in Patients with Acute Myeloid Leukemia

被引：11

作者：

Zeidan, Amer M. ^{[1
,2
]}

Schuster, Michael W. ^{[3
]}

Krauter, Jurgen ^{[4
]}

Maertens, Johan A. ^{[5
]}

Gyan, Emmanuel ^{[6
]}

Joris, Magalie ^{[7
]}

Menne, Tobias F. ^{[8
]}

Vyas, Paresh ^{[9
]}

Ma, Weidong Wendy ^{[10
]}

O'Connell, Ashleigh ^{[10
]}

Zeremski, Mirjana ^{[10
]}

Kudla, Arthur ^{[10
]}

Chan, Geoffrey

Sekeres, Mikkael A. ^{[11
]}

机构：

[1] Yale Sch Med, New Haven, CT USA

[2] Yale Canc Ctr, New Haven, CT USA

[3] Stony Brook Univ Hosp, Canc Ctr, Stony Brook, NY USA

[4] Med Klinikum Braunschweig GmbH, Dept Internal Med 3, Braunschweig, Germany

[5] UZ Leuven, Leuven, Belgium

[6] CHU Tours, Hop Bretonneau, Tours, France

[7] CHU Amiens Picardie, Amiens, France

[8] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Dept Haematol, Newcastle Upon Tyne, Tyne & Wear, England

[9] Univ Oxford, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford, England

[10] Pfizer Oncol, New York, NY USA

[11] Cleveland Clin, Leukemia Program, Cleveland, OH 44106 USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-124034

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3916

引用

页数：5

共 50 条

[41] ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS NOT CONSIDERED FIT FOR INTENSIVE TREATMENT; AZACITIDINE, LOW DOSE CYTARABINE AND ETOPOSID COMBINATION EXPERIENCE FROM A SINGLE CENTER [J].

Okutan, H. ;

Onec, B. ;

Albayrak, M. ;

Aslan, V. ;

Can, E. ;

Kosemehmetoglu, O. ;

Koluman, B. ;

Albayrak, A. .

HAEMATOLOGICA, 2013, 98 :531-531

[42] High Activity of Cladribine (2-CdA) Combined with Low-Dose Cytarabine in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome after Azacitidine Failure [J].

Wisniewski, Kamil ;

Madry, Krzysztof ;

Grosicki, Sebastian ;

Malecki, Piotr ;

Pula, Bartosz ;

Watek, Marzena ;

Lech-Maranda, Ewa ;

Tybor, Joanna Gora .

BLOOD, 2019, 134

[43] Low-Dose Venetoclax with Azacitidine in Adults with Acute Myeloid Leukemia: Impact of Phenotype on Outcomes [J].

Ugarte, Luis ;

Lopez-Garcia, Yadith Karina ;

De La Garza, Fernando ;

Rubio, Francisco ;

Morcos, Michelle ;

Gonzalez, Alexia ;

Vasquez, Ana Cristina Tejada ;

Mateos, Antonio Vega ;

Garcia-Salas, Gerardo ;

Colunga-Pedraza, Perla R. ;

Gomez-Almaguer, David ;

Gomez-De Leon, Andres .

BLOOD, 2024, 144 :5964-5965

[44] ORAL IDARUBICIN AND LOW-DOSE CYTARABINE AS THE INITIAL TREATMENT OF ACUTE MYELOID-LEUKEMIA IN ELDERLY PATIENTS [J].

HAROUSSEAU, JL ;

HUGUET, F ;

REIFFERS, J ;

COLLOMBAT, P ;

KOHSER, P ;

LEPRISE, PY ;

SOUTEYRAND, P ;

HURTELOUP, P .

LEUKEMIA & LYMPHOMA, 1991, 5 (2-3) :145-149

[45] Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy [J].

Laloi, Louise ;

Billotey, Natacha Chaumard ;

Dumas, Pierre-Yves ;

Paul, Franciane ;

Villate, Alban ;

Simand, Celestine ;

Fornecker, Luc ;

Puisset, Florent ;

Bertoli, Sarah ;

Simonet, Marion Boissard ;

Laribi, Kamel ;

Houyou, Dyhia ;

Santagostino, Alberto ;

Michel, Claire ;

Guepin, Gabrielle Roth ;

Guerineau, Elodie ;

Tabrizi, Reza ;

Hunault, Mathilde ;

Giltat, Aurelien ;

Kaphan, Eleonore ;

Bulabois, Claude ;

Cartet, Elodie ;

Rocher, Clement ;

Lachenal, Florence ;

Morisset, Stephane ;

Recher, Christian ;

Pigneux, Arnaud ;

Belhabri, Amine ;

Michallet, Mauricette ;

Michallet, Anne-Sophie .

CANCER MEDICINE, 2023, 12 (06) :7175-7181

[46] Azacitidine and low-dose cytarabine in palliative patients with acute myeloid leukemia and high bone marrow blast counts - a retrospective single-center experience [J].

Radujkovic, Aleksandar ;

Dietrich, Sascha ;

Bochtler, Tilmann ;

Kraemer, Alwin ;

Schoening, Tilman ;

Ho, Anthony D. ;

Dreger, Peter ;

Luft, Thomas .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (02) :112-117

[47] Low-dose combination chemotherapy for acute myeloid leukemia in elderly patients: A novel approach [J].

Manoharan, A ;

Baker, RI ;

Kyle, PW .

AMERICAN JOURNAL OF HEMATOLOGY, 1997, 55 (02) :115-117

[48] Pilot study on combination of azacitidine and low-dose cytarabine for patients with refractory anemia with excess blast [J].

Joon Ho Moon ;

Soo Jung Lee ;

Yoo Jin Lee ;

Byung Woog Kang ;

Yee Soo Chae ;

Jong Gwang Kim ;

Jang Soo Suh ;

Sang Kyun Sohn .

Annals of Hematology, 2012, 91 :367-373

[49] Pilot study on combination of azacitidine and low-dose cytarabine for patients with refractory anemia with excess blast [J].

Moon, Joon Ho ;

Lee, Soo Jung ;

Lee, Yoo Jin ;

Kang, Byung Woog ;

Chae, Yee Soo ;

Kim, Jong Gwang ;

Suh, Jang Soo ;

Sohn, Sang Kyun .

ANNALS OF HEMATOLOGY, 2012, 91 (03) :367-373

[50] Autophagy is an important event for low-dose cytarabine treatment in acute myeloid leukemia cells [J].

Chen, Liyun ;

Guo, Pei ;

Zhang, Yunxiang ;

Li, Xiaoyang ;

Jia, Peimin ;

Tong, Jianhua ;

Li, Junmin .

LEUKEMIA RESEARCH, 2017, 60 :44-52

← 1 2 3 4 5 →